NCT04984317View on ClinicalTrials.gov

Feasibility of BOTOX Injection on Improving Female Stress Urinary Incontinence

EARLY_PHASE1SuspendedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 14, 2022

Primary Completion Date

April 30, 2025

Study Completion Date

August 31, 2025

Conditions
Stress Urinary Incontinence
Interventions
DRUG

onabotulinumtoxin A

One-time injection of 100U BOTOX

Trial Locations (1)

10065

Weill Cornell Medicine, New York

Sponsors

Lead Sponsor

Northwell Health

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Northwell Health

OTHER

NCT04984317 - Feasibility of BOTOX Injection on Improving Female Stress Urinary Incontinence | Biotech Hunter | Biotech Hunter